Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases
Clinical trial NCT03856658 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03856658
- Sponsor
- Corewell Health West
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-05
- Primary completion
- 2028-12-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.